Studies CONFIRMING Thimerosal as a Health Hazard
Thimerosal DOES HAVE a very real, detrimental impact on health, and that mercury toxicity is a reality in those suffering from the type of neurological damage seen in autistic children.
Environmental Health Perspectives, August, 2005
Fourteenstudies.org states: “This study demonstrates clearly and unequivocally that ethyl mercury, the kind of mercury found in vaccines, not only ends up in your brain, but leaves double the amount of inorganic mercury as methyl mercury, the kind of mercury found in fish.
This work is groundbreaking because little is known about ethyl mercury, and many health authorities have asserted that the mercury found in vaccines is the "safe kind."
This study also delivers a strong rebuke of the Institute of Medicine's recommendation in 2004 to no longer pursue the mercury-autism connection. Excerpt:
"A recently published IOM review (IOM 2004) appears to have abandoned the earlier recommendation [of studying mercury and autism] as well as back away from the American Academy of Pediatrics goal [of removing mercury from vaccines].
This approach is difficult to understand, given our current limited knowledge of the toxicokinetics and developmental neurotoxicity of thimerosal, a compound that has been (and will continue to be) injected in millions of newborns and infants."
Cell Biology and Toxicology April 9, 2009 [Epub Ahead of Print]
Exerpt: “In conclusion, MT-1 and MT-3 mRNAs but not MT-2 mRNA are easily expressed in the cerebellum rather than in the cerebrum by the injection of low-dose thimerosal. It is thought that the cerebellum is a sensitive organ against thimerosal.
As a result of the present findings, in combination with the brain pathology observed in patients diagnosed with autism, the present study helps to support the possible biological plausibility for how low-dose exposure to mercury from thimerosal-containing vaccines may be associated with autism.”
Annals of Epidemiology September 2009: 19(9);659
Male infants who received thimerosal-containing hepatitis-B vaccinations had a three-fold risk of developing autism.
Neurotoxicology October 1, 2009
The above findings are confirmed in this study wherein infant primates injected with just ONE dose of thimerosal-containing hepatitis B vaccine manifested significant developmental delays.
Brain Research September 9, 2009 [Epub Ahead of Print]
Study concluded that injecting thimerosal into suckling infant rats, and adult rats, impairs sensitivity to pain, apparently due to activation the endogenous opioid system.
Toxicology & Environmental Chemistry September-October 2008: 90(5);997-1008
Male infants who received thimerosal-containing hepatitis-B vaccinations were nine times as likely to be receiving special education services
Generation Rescue Survey of 9,000 boys, aged 4-17, in California and Oregon, found that vaccinated boys had a 155 percent greater chance of having a neurological disorder than unvaccinated boys. Vaccinated boys were 224 percent more likely to have Attention Deficit Hyperactivity Disorder (ADHD), and 61 percent more likely to have autism.
For boys in the 11-17 age bracket, the results were even more pronounced. Vaccinated boys were 158 percent more likely to have a neurological disorder, 317 percent more likely to have ADHD, and 112 percent more likely to have autism.
Report to the Legislature on the Principle Findings from The Epidemiology of Autism in California: A Comprehensive Pilot Study by the MIND Institute, October 2002, concluded that the rise in autism cannot be explained by better diagnosis and expanded diagnostic criteria, but rather is a real event, likely propelled by “environmental exposures to substances such as mercury; viral exposures; autoimmune disorders; and childhood vaccinations."
Toxicology and Applied Pharmacology 2006: 214; 99-108
This French study used a new, sophisticated measurement for environmental toxicity by assessing porphyrin levels in autistic children. It provides clear and unequivocal evidence that children with autism spectrum disorders are significantly more toxic than their neurotypical peers.
Journal of American Physicians and Surgeon, 2003
Exerpt: "The data from this study, along with emerging epidemiological data showing a link between increasing mercury doses from childhood vaccines and childhood neurodevelopmental disorders, increases the likelihood that mercury is one of the main factors leading to the large increase in the rate of autism and other neurodevelopmental disorders. It is hoped that removing thimerosal from all childhood vaccines will contribute to a decline in the numbers of new cases of autistic spectrum disorders."
Journal of Toxicology and Environmental Health 2007: 70; 837-851
This study reviewed the case histories and medical profiles of nine autistic children and concluded that eight of the nine children were mercury toxic and this toxicity manifested itself in a manner consistent with Autism Spectrum Disorders.
Neuropediatrics, August 2006
Exerpt: "There was significant difference in blood mercury levels between cases and controls, which persists after adjustment for age, gender and parental occupational status. The geometric mean blood mercury level was also significantly higher in children with inattentive and combined subtypes of ADHD. CONCLUSION: High blood mercury level was associated with ADHD. Whether the relationship is causal requires further studies."
International Journal of Toxicology 2003: 22; 277-285
Fourteenstudies.org states: “This recent study demonstrates that the levels of mercury in the birth hair of autistic children were significantly lower than their control peers. While this may at first appear contradictory, it highlights one of the critical insights to understanding mercury poisoning and autistic children: many autistic children are non-excretors of mercury. This means their capacity to excrete mercury is significantly lower than their neurotypical peers and contributes to their condition.”
Journal of Pediatrics, May 2000: 136; 679-681
This study measured mercury levels in infants before and after the administration of a Hepatitis B vaccine containing thimerosal and found that a "comparison of pre and post-vaccination mercury levels showed a significant increase in both preterm and term infants after vaccination."
Neurotoxicology January 2005: 26; 1-8
Study demonstrates that thimerosal lowers or inhibits your body's ability to produce glutathione, an antioxidant and your body's primary cellular-level defense against mercury.
Excerpt: "Thimerosal-induced cytotoxicity was associated with depletion of intracellular Glutathione in both cell lines...The potential effect of Glutathione or N-acetylcysteine against mercury toxicity warrants further research as possible adjunct therapy to individuals still receiving Thimerosal-containing vaccines."
Environmental Health Perspectives, July 2006
Study demonstrates that very low-levels of Thimerosal can contribute to immune system disregulation.
Molecular Psychiatry July 2004; 1-13
Study demonstrates how thimerosal inhibits methylation, a central driver of cellular communication and development.
Exerpt: "The potent inhibition of this pathway [methylation] by ethanol, lead, mercury, aluminum, and thimerosal suggests it may be an important target of neurodevelopmental toxins."
Molecular Psychiatry September 2004; 1-13
Fouteenstudies.org states: “This work by Columbia University Doctors explores whether genes are important in determining if mercury exposures akin to those in childhood immunizations can disrupt brain development and function.
It is the first known scientific study done specifically on ethlymercury administered in a way similar to the vaccine schedule. Dr. Hornig discussed the study before Congress in September 2004.”
Excerpt: "The premise of our research is that if mercury in vaccines creates risk for neurodevelopmental disorders such as autism, genetic differences are likely to contribute to that risk. Earlier studies, however, did not use the form of mercury present in vaccines, known as thimerosal, and did not consider whether intramuscular, repetitive administration during early postnatal development, when the brain and immune systems are still maturing, might intensify toxicity.
Our predictions were confirmed. Using thimerosal dosages and timing that approximated the childhood immunization schedule, our model of postnatal thimerosal neurotoxicity demonstrated that the genes in mice that predict mercury-related immunotoxicity also predicted nuerodevelopmental damage. Features reminiscent of those observed in autism occurred in the mice of the genetically sensitive strain."
Toxicological Sciences 2003: 74
Study demonstrates the potent toxicity of thimerosal on brain cells.
Autoimmunity Reviews June 2005: 4(5):270-275
Study demonstrates the clear link between ethylmercury [from thimerosal] and autoimmune responses.
Congressional Record - Extensions of Remarks by Congressman Dan Burton (R-IN), Committee on Government Reform, May 21, 2003
Fouteenstudies.org states: “This extensive report was prepared by the staff of the Subcommittee on Human Rights and Wellness and was the result of a three-year investigation. The Committee on Government Reform, chaired by Congressman Dan Burton, initiated the investigation and compiled the testimony of hundreds of researchers and physicians, as well as representatives from the FDA and CDC, who presented to the committee.”
Excerpt: "Mercury is hazardous to humans. Its use in medicinal products is undesirable, unnecessary and should be minimized or eliminated entirely. Manufacturers of vaccines and thimerosal, (an ethlymercury compound used in vaccines), have never conducted adequate testing on the safety of thimerosal. The FDA has never required manufacturers to conduct adequate safety testing on thimerosal and ethlymercury compounds...
Thimerosal used as a preservative in vaccines is likely related to the autism epidemic. This epidemic in all probability may have been prevented or curtailed had the FDA not been asleep at the switch regarding injected thimerosal and the sharp rise of infant exposure to this known neurotoxin. Our public health agencies' failure to act is indicative of institutional malfeasance for self-protection and misplaced protectionism of the pharmaceutical industry."
Journal of American Physicians and Surgeons 2006; 11(1); 8-13
Upon analysis of the Vaccine Adverse Events Reporting System (VAERS), researchers reported significantly increased odds ratios for autism, speech disorders, mental retardation and thinking abnormalities following vaccination with thimerosal-containing vaccines (DTP and Hib), compared to children who received a vaccine containing half the amount of thimerosal (DTPH).
The American Academy of Pediatrics decided that this study was flawed because it relied on VAERS data, which as a “passive surveillance system” is no intended to be used for proving hypotheses.